Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology

American Journal of Ophthalmology

Volumn 125, Issue 6, 1998, Pages 819-829

  Quigley, Harry A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; OPTIC DISK; PERIMETRY; PRIORITY JOURNAL; SCREENING TEST; TECHNOLOGY; VISION TEST; VISUAL FIELD DEFECT;

AGED; FEMALE; GLAUCOMA; HUMANS; MALE; NERVE FIBERS; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE; PERIMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VISION DISORDERS; VISUAL FIELDS;

EID: 0032101540     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00046-4     Document Type: Article

References (32)

1. Quigley H.A. The number of persons with glaucoma worldwide. Br J Ophthalmol. 80:1996;389-393.
2. Gottlieb L.K., Schwartz B., Pauker S.G. Glaucoma screening a cost-effectiveness analysis . Surv Ophthalmol. 28:1983;206-226.
3. Boivin J.F., McGregor M., Archer C. Cost effectiveness of screening for primary open angle glaucoma. J Med Screen. 3:1996;154-163.
4. Tielsch J.M., Katz J., Singh K., et al. A population-based evaluation of glaucoma screening the Baltimore Eye Survey . Am J Epidemiol. 134:1991;1102-1110.
5. Asai T., Katsumori N., Mizokami K. Retinal ganglion cell damage in human glaucoma, 2 studies on damage pattern . Nippon Ganka Gakkai Zasshi. 91:1987;1204-1213.
6. Quigley H.A., Dunkelberger G.R., Baginski T.A., Green W.R. Chronic human glaucoma causes selectively greater loss of large optic nerve fibers. Ophthalmology. 95:1988;357-363.
7. Glovinsky Y., Quigley H.A., Dunkelberger G.R. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 32:1991;484-491.
8. Dandona L., Hendrickson A., Quigley H.A. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus. Invest Ophthalmol Vis Sci. 32:1991;1593-1599.
9. Glovinsky Y., Quigley H.A., Pease M.E. Foveal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 34:1993;395-400.
10. Chaturvedi N., Hedley-Whyte E.T., Dreyer E.B. Lateral geniculate nucleus in glaucoma. Am J Ophthalmol. 116:1993;182-188.
11. Vickers J.C., Shumer R., Podos S., Wang R.F., Morrison J.H. Selective vulnerability of neurochemically coded subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res. 680:1995;23-35.
12. Weber A.J., Chen H., Kaufman P.L., Hubbard W.C. Effects of elevated IOP on cell size, density and number in the primate lateral geniculate nucleus (LGN). ARVO abstracts. Invest Ophthalmol Vis Sci. 38:(4suppl):1997;159.
13. Tyler C.W. Specific deficits of flicker sensitivity in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 20:1981;204-212.
14. Atkin A., Bodis-Wollner I., Wolkstein M., Moss A. Abnormalities of central contrast sensitivity in glaucoma. Am J Ophthalmol. 88:1979;205-211.
15. Silverman S.E., Trick G.L., Hart W.M. Motion perception is abnormal in primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 31:1990;722-729.
16. Bullimore M.A., Wood J.M., Swenson K. Motion perception in glaucoma. Invest Ophthalmol Vis Sci. 34:1993;3526-3533.
17. Baez K.A., McNaught A.I., Dowler J.G., Poinoosawmy D., Fitzke F.W., Hitchings R.A. Motion detection threshold and field progression in normal tension glaucoma. Br J Ophthalmol. 79:1995;125-128.
18. Glovinsky Y., Quigley H.A., Drum B., Bissett R.A., Jampel H.D. A whole-field scotopic retinal sensitivity test for the detection of early glaucoma damage. Arch Ophthalmol. 110:1992;486-489.
19. Kelly D.H. Frequency doubling in visual responses. J Opt Soc Am. 56:1996;1628-1633.
20. Maddess T., Henry G.H. Performance of nonlinear visual units in ocular hypertension and glaucoma. Clin Vision Sci. 7:1992;371-383.
21. Kaplan E., Shapley R.M. X and Y cells in the lateral geniculate nucleus of macaque monkeys. J Physiol. 330:1982;125-143.
22. Johnson C.A., Samuels S.J. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 38:1997;413-425.
23. Quigley H.A., Reacher M., Katz J., Strahlman E., Gilbert D., Scott R. Quantitative grading of nerve fiber layer photographs. Ophthalmology. 100:1993;1800-1807.
24. Katz J., Sommer A., Gaasterland D.E., Anderson D.R. Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol. 109:1991;1684-1689.
25. Damato B.E., Chyla J., McClure E., Jay E.L., Allen D. A hand-held OKP chart for the screening of glaucoma preliminary evaluation . Eye. 4:1990;632-637.
26. Vernon S.A., Quigley H.A. A comparison of the OKP visual field screening test with the Humphrey field analyser. Eye. 6:1992;521-524.
27. Sponsel W.E., Ritch R., Stamper R., Higginbotham E.J., Anderson D.R., Wilson M.R., Zimmerman T.J. Prevent Blindness America visual field screening study. Am J Ophthalmol. 120:1995;699-708.
28. Henson D.B., Chauhan B.C., Hobley A. Screening for glaucomatous visual field defects the relationship between sensitivity, specificity, and the number of test locations . Ophthalmic Physiol Opt. 8:1988;123-127.
29. Henson D.B., Chauhan B.C. Informational content of visual field locations in glaucoma. Doc Ophthalmol. 59:1985;341-352.
30. Zeyen T.G., Zulauf M., Caprioli J. Priority of test locations for automated perimetry in glaucoma. Ophthalmology. 100:1993;518-522.
31. Johnson C.A. Selective versus nonselective losses in glaucoma. J Glaucoma. 3:(suppl):1994;S32-S44.
32. Quigley H.A., Dunkelberger G.R., Green W.R. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 107:1989;453-464.